Uwe Zeymer

Summary

Country: Germany

Publications

  1. ncbi request reprint Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial
    U Zeymer
    Medizinische Klinik II, Klinikum Kassel, , D-34125 Kassel, Federal Republic of Germany
    Eur Heart J 22:769-75. 2001
  2. ncbi request reprint Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study
    A K Gitt
    Department of Cardiology, Herzzentrum Ludwigshafen, Bremser Strasse 79, D 67063, Ludwigshafen, Germany
    Acta Diabetol 40:S343-7. 2003
  3. doi request reprint Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry
    U Zeymer
    Medizinische Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
    Int J Clin Pract 66:251-61. 2012
  4. pmc Management of acute coronary syndromes with fondaparinux
    Harm Wienbergen
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Germany
    Vasc Health Risk Manag 3:321-9. 2007
  5. doi request reprint Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR)
    Uwe Zeymer
    Institut für Herzinfarktforschung, Ludwigshafen, Germany Electronic address
    Int J Cardiol 170:239-45. 2013
  6. doi request reprint Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry
    Uwe Zeymer
    Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Clin Res Cardiol 102:223-7. 2013
  7. doi request reprint Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial
    Uwe Zeymer
    Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Clin Res Cardiol 101:305-12. 2012
  8. pmc Midventricular form of takotsubo cardiomyopathy as a recurrence 1 year after typical apical ballooning: a case report
    Oliver Koeth
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Cases J 1:331. 2008
  9. ncbi request reprint Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 27:2661-6. 2006
  10. ncbi request reprint Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Am J Cardiol 98:19-22. 2006

Detail Information

Publications112 found, 100 shown here

  1. ncbi request reprint Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial
    U Zeymer
    Medizinische Klinik II, Klinikum Kassel, , D-34125 Kassel, Federal Republic of Germany
    Eur Heart J 22:769-75. 2001
    ....
  2. ncbi request reprint Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study
    A K Gitt
    Department of Cardiology, Herzzentrum Ludwigshafen, Bremser Strasse 79, D 67063, Ludwigshafen, Germany
    Acta Diabetol 40:S343-7. 2003
    ..Intensifying secondary prevention by a more frequent use of established pharmaceutical regimes might improve the prognosis of diabetics after STEMI and prevent cardiovascular and cerebrovascular events...
  3. doi request reprint Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry
    U Zeymer
    Medizinische Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
    Int J Clin Pract 66:251-61. 2012
    ..So far little is known about the use and efficacy of aliskiren in the treatment of essential hypertension under clinical practice conditions...
  4. pmc Management of acute coronary syndromes with fondaparinux
    Harm Wienbergen
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Germany
    Vasc Health Risk Manag 3:321-9. 2007
    ..In summary, fondaparinux is a new antithrombin that is an efficient, safe, and easy to use in treatment for STEMI patients, particularly those not undergoing primary PCI...
  5. doi request reprint Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR)
    Uwe Zeymer
    Institut für Herzinfarktforschung, Ludwigshafen, Germany Electronic address
    Int J Cardiol 170:239-45. 2013
    ....
  6. doi request reprint Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry
    Uwe Zeymer
    Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Clin Res Cardiol 102:223-7. 2013
    ..We sought to investigate the use and impact of the outcome of IABP in current practice of percutaneous coronary interventions in Germany...
  7. doi request reprint Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial
    Uwe Zeymer
    Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Clin Res Cardiol 101:305-12. 2012
    ..To compare a loading dose of 600 mg clopidogrel given in the prehospital phase versus clopidogrel administered only after the diagnostic angiogram in patients with STEMI scheduled for primary PCI...
  8. pmc Midventricular form of takotsubo cardiomyopathy as a recurrence 1 year after typical apical ballooning: a case report
    Oliver Koeth
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Cases J 1:331. 2008
    ..Recurrences of Takotsubo Cardiomyopathy, especially in variant regions of the left ventricle are rareWe describe a midventricular form of Takotsubo Cardiomyopathy as a recurrence 1 year after typical apical ballooning...
  9. ncbi request reprint Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 27:2661-6. 2006
    ..We sought to assess the effect of clopidogrel on clinical events 1 year after discharge in survivors of ST-elevation myocardial infarction (STEMI) in clinical practice...
  10. ncbi request reprint Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Am J Cardiol 98:19-22. 2006
    ....
  11. ncbi request reprint Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Int J Cardiol 107:11-20. 2006
    ..006) and the risk of a myocardial infarction by 64% (P=0.012). These results suggest that acarbose is useful in reducing the risk of cardiovascular events in patients with impaired glucose metabolism...
  12. ncbi request reprint The role of eptifibatide in patients undergoing percutaneous coronary intervention
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Expert Opin Pharmacother 8:1147-54. 2007
    ..After the completion of these trials, the value of etifibatide in patients undergoing PCI in different indications can be determined...
  13. ncbi request reprint Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)
    U Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:392-8. 2005
    ..The ALKK registry contains about 20% of the invasive and interventional cardiological procedures performed in Germany...
  14. ncbi request reprint Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinsche Klinik B, Ludwigshafen, Germany
    Acute Card Care 10:43-8. 2008
    ..We sought to assess the effect of clopidogrel on one-year ischemic events in unselected patients with NSTEMI...
  15. ncbi request reprint [Secondary prevention in outpatients with coronary artery disease. Adherence with recommendations within 4 weeks after hospital discharge]
    U Zeymer
    Medizinische Klinik B, Ludwigshafen, Herzzentrum Ludwigshafen, und Institut für Herzinfarktforschung an der Universität Heidelberg, Ludwigshafen, Deutschland
    Dtsch Med Wochenschr 132:2367-70. 2007
    ..There is little information about adherence with secondary preventive medication by patients with coronary artery disease (CHD) shortly after hospital discharge...
  16. ncbi request reprint A review of clinical trials with eptifibatide in cardiology
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Cardiovasc Drug Rev 25:301-15. 2007
    ..Current studies are evaluating eptifibatide as upstream therapy in high-risk patients with NSTE-ACS, in the EARLY-ACS and in comparison with abciximab in patients with primary PCI in the EVA-AMI trial...
  17. doi request reprint Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Germany
    Thromb Haemost 99:150-4. 2008
    ....
  18. doi request reprint Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Thromb Haemost 99:155-60. 2008
    ..This advantage was associated with an increase in major bleeding complications...
  19. doi request reprint Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    EuroIntervention 7:437-41. 2011
    ..We sought to investigate the use and impact on mortality of IABP in current practice of percutaneous coronary interventions in Europe...
  20. ncbi request reprint [Myocardial infarction 2009--Randomized studies vs. clinical daily routine]
    U Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen
    Dtsch Med Wochenschr 134:S190-1. 2009
    ..Therefore prospective STEMI registries are an important part in the continuous effort to improve the care of patients with acute myocardial infarction...
  21. doi request reprint [Registries of myocardial infarction in Germany. Consequences for drug therapy of patients with acute ST elevation myocardial infarction]
    U Zeymer
    Medizinische Klinik B, Klinikum der Stadt Ludwigshafen gGmbH, Ludwigshafen, Deutschland
    Internist (Berl) 51:1324-7, 1329. 2010
    ..Therefore prospective STEMI registries are an important part of clinical research to optimize therapies and improve outcome in patients with STEMI...
  22. ncbi request reprint Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    J Am Coll Cardiol 56:463-9. 2010
    ..The aim of this study was to compare eptifibatide and abciximab as adjuncts to primary percutaneous coronary intervention (PCI)...
  23. ncbi request reprint Glycoprotein IIb/IIIa antagonists: new developments
    U Zeymer
    Herzzentrum Ludwigshafen und Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany
    Hamostaseologie 29:334-7; quiz 338. 2009
    ..Comparative trials evaluating the effectiveness of abciximab and the small molecules tirofiban and eptifibatide did not show any differences between the three GP IIb/IIIa antagonists...
  24. doi request reprint Beneficial effect of reperfusion therapy beyond the preservation of left ventricular function in patients with acute ST-segment elevation myocardial infarction
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klink B, Ludwigshafen, Germany
    Int J Cardiol 146:177-80. 2011
    ..However, in randomized clinical trials there was only a modest improvement in left ventricular ejection fraction with reperfusion therapy, despite a larger improvement in mortality...
  25. ncbi request reprint Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    EuroIntervention 4:524-8. 2009
    ..We sought to determine the efficacy of enoxaparin in unselected patients with STEMI treated with primary percutaneous coronary intervention in clinical practice...
  26. doi request reprint Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 98:249-56. 2009
    ..We compared patients with PAD only with those having PAD and concomitant documented CAD in terms of characteristics, risk factors, treatment and prognosis...
  27. doi request reprint Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR)
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Germany Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Ludwigshafen, Germany
    Resuscitation 80:402-6. 2009
    ..We sought to evaluate the in-hospital fate of patients with ST segment elevation myocardial infarction (STEMI) diagnosed already in the prehospital phase by physican equipped ambulances...
  28. ncbi request reprint Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design
    Uwe Zeymer
    Herzzentrum Ludwigshafen und Institut fur Herzinfarktforschung, Ludwigshafen, Germany
    Cardiology 108:265-72. 2007
    ..The primary efficacy endpoint is the TIMI 2/3 patency of the infarct-related artery immediately prior to PCI. The rationale, design and methods of this study are described...
  29. ncbi request reprint Coronary aneurysms
    U Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:303-4. 2005
  30. ncbi request reprint [Mortality of patients who are older than 75 years after ST elevation myocardial infarction in clinical practice]
    U Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B
    Dtsch Med Wochenschr 130:633-6. 2005
    ..Patients who are older than 75 years are often excluded in clinical trials evaluating therapies for ST elevation myocardial infarction. Therefore there is a lack of prospective data for this steadily increasing number of elderly patients...
  31. ncbi request reprint Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Eur J Cardiovasc Prev Rehabil 11:412-5. 2004
    ..In the randomised STOP-NIDDM trial, we could demonstrate that lowering postprandial plasma glucose with acarbose in subjects with impaired oral glucose tolerance could reduce the risk of diabetes...
  32. ncbi request reprint [Quality registries in cardiology]
    U Zeymer
    Herzzentrum Ludwigshafen, Ludwigshafen
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:533-9. 2004
    ..g., withholding guideline- adherent therapies. With this feature an increase in the use of guideline-adherent therapies could be observed, which was associated with an improvement in clinical outcome...
  33. ncbi request reprint [Bolus fibrinolysis in acute myocardial infarction]
    U Zeymer
    Medizinische Klinik B, Klinikum Ludwigshafen, Germany
    Dtsch Med Wochenschr 127:2083-6. 2002
  34. ncbi request reprint Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende K
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Eur Heart J 25:322-8. 2004
    ..Our results seen in connection with the results of the randomized SHOCK study advocate an early invasive approach in younger patients with cardiogenic shock, while the best strategy in elderly patients is still a matter of debate...
  35. ncbi request reprint [Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry]
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum, Ludwigshafen
    Herz 29:651-5. 2004
    ..The aim of the present prospective registry was to evaluate the efficacy and safety of eptifibatide in clinical practice...
  36. ncbi request reprint Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 26:1971-7. 2005
    ..Little is known about the use of eptifibatide in this setting...
  37. ncbi request reprint The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial
    U Zeymer
    Medizinische Klinik II, Klinikum Kassel, Kassel, Germany
    J Am Coll Cardiol 38:1644-50. 2001
    ....
  38. ncbi request reprint ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Am Heart J 149:91-7. 2005
    ..To improve the ease of this method in clinical practice, we sought to evaluate the optimal cutoffs and the prognostic value of ST resolution (STR) measured in a single ECG lead...
  39. ncbi request reprint Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
    Uwe Zeymer
    Medizinische Klinik II, Klinikum Kassel, Berlin, Germany
    Circulation 108:1324-8. 2003
    ..Despite the lack of randomized studies, it is widely believed that this intervention will improve the clinical outcome of these patients...
  40. ncbi request reprint [Who benefits from late recanalization after acute myocardial infarction?]
    U Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B
    Dtsch Med Wochenschr 129:759-63. 2004
  41. ncbi request reprint Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial
    Uwe Zeymer
    Medizinische Klinik II, Klinikum Kassel, Germany
    J Invasive Cardiol 15:385-9. 2003
    ..Therefore, there is still need to evaluate therapy strategies in these patients...
  42. ncbi request reprint Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?
    Uwe Zeymer
    Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    J Thromb Thrombolysis 15:91-7. 2003
  43. ncbi request reprint Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction
    Uwe Zeymer
    Medizinische Klinik II, Klinikum Kassel, Kassel, Germany
    Am Heart J 146:686-91. 2003
    ..The aim of this study was to compare early ST resolution in patients treated with primary percutaneous transluminal coronary angioplasty (PTCA) or thrombolytic therapy for AMI...
  44. doi request reprint Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction
    Timm Bauer
    Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Cardiol 32:718-23. 2009
    ..Little is known about the influence of chronic antithrombotic therapy on treatment and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI)...
  45. doi request reprint Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry)
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Am J Cardiol 104:1074-7. 2009
    ..Hospital mortality in those patients is very high. Primary PCI improves the prognosis and is therefore the preferred reperfusion strategy in these patients...
  46. doi request reprint Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence
    Timm Bauer
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Eur J Cardiovasc Prev Rehabil 17:576-81. 2010
    ..Our objectives were to determine factors of, and to measure outcomes associated with nonadherence after MI...
  47. ncbi request reprint Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry
    Timm Bauer
    Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen, Germany Universitätsklinik Gießen, Germany Electronic address
    Int J Cardiol 168:5239-42. 2013
    ..We sought to determine the clinical significance of ST elevations in patients with LCX-related myocardial infarction...
  48. doi request reprint Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry
    Timm Bauer
    Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Heidelberg, Germany
    Heart Vessels 27:453-9. 2012
    ..In Europe almost half of all patients with multivessel disease were treated with MV-PCI. Hospital complications were low, but a trend toward a higher rate of postprocedural myocardial infarctions was seen in patients with MV-PCI...
  49. doi request reprint Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 98:781-6. 2009
    ..The aim of our analysis is to assess gender differences in baseline characteristics, acute therapies, and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock...
  50. ncbi request reprint Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Catheter Cardiovasc Interv 74:1-8. 2009
    ..To determine the influence of the side intervened upon on outcomes during carotid artery stenting (CAS)...
  51. ncbi request reprint Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction
    Harm Wienbergen
    Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung, Ludwigshafen, Germany
    Am J Cardiol 99:1208-11. 2007
    ..High-risk patients with STEMI, such as elderly patients and patients without reperfusion therapy, showed a greater benefit of acute beta-blocker therapy than low-risk patients with STEMI...
  52. ncbi request reprint Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Am J Cardiol 95:1302-8. 2005
    ..The management of bypass grafts and multiple lesions in 1 session and the presence of multivessel disease were predictors of MACCEs or TVR...
  53. doi request reprint Age-related differences in antithrombotic therapy, success rate and in-hospital mortality in patients undergoing percutaneous coronary intervention: results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzt
    Arne Kristian Schwarz
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 100:773-80. 2011
    ..This analysis examines the influence of age on antithrombotic therapy, success rate of percutaneous coronary intervention (PCI) and in-hospital mortality in patients with Acute Coronary Syndrome (ACS) and elective PCI...
  54. ncbi request reprint Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction
    Timm Bauer
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    J Cardiovasc Pharmacol 53:132-6. 2009
    ..We sought to investigate the impact of prior statin therapy on in-hospital outcome in patients presenting with acute non-ST-elevation myocardial infarction...
  55. doi request reprint Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories
    Patricia Krüth
    Herzzentrum, Med Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 97:742-7. 2008
    ..However little is known about the impact of admission on weekend in hospitals with catheterisation laboratories...
  56. ncbi request reprint Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction
    Timm Bauer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 28:2873-8. 2007
    ..We sought to investigate the impact of an invasive treatment in elderly patients presenting with non-ST elevation myocardial infarction (NSTEMI) in clinical practice...
  57. doi request reprint Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry
    Ralf Zahn
    Med Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 99:99-106. 2010
    ..Treatment of restenosis following intracoronary brachytherapy (ICB) is still a challenging problem. Implantation of sirolimus-eluting stents (SES) in this setting may be an option to be evaluated...
  58. doi request reprint Reperfusion therapy for acute ST-elevation and non ST-elevation myocardial infarction: what can be achieved in daily clinical practice in unselected patients at an interventional center?
    Ralf Zahn
    Heart Center, Department of Cardiology, Ludwigshafen, Germany
    Acute Card Care 11:92-8. 2009
    ..The characterization of AMI patients according to this definition is still incomplete...
  59. doi request reprint Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry
    Timm Bauer
    Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany
    Int J Cardiol 166:596-600. 2013
    ..Therefore, we sought to evaluate the impact of MV-PCI on in-hospital outcome of patients with MV disease presenting with ACS...
  60. doi request reprint Carotid artery stenting in clinical practice: does sex matter? Results from the carotid artery stenting registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Nicolas Werner
    Herzzentrum, Kardiologie, Ludwigshafen, Städtisches Klinikum, Germany
    Clin Cardiol 35:111-8. 2012
    ..A possible impact of the patient's gender on the outcome of patients undergoing CAS has not been investigated properly and only little information about this topic is available so far...
  61. doi request reprint Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome. Results of the MITRA plus registry
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Klinikum Ludwigshafen, Bremserstr 79, 67063 Ludwigshafen am Rhein, Germany
    Clin Res Cardiol 98:107-13. 2009
    ..Percutaneous coronary intervention (PCI) early after thrombolysis (early PCI) in patients with ST-elevation myocardial infarction (STEMI) is currently advised by clinical guidelines, but little is known about its use in clinical practice...
  62. doi request reprint Primary percutaneous coronary intervention and thrombolysis improve survival in patients with ST-elevation myocardial infarction and pre-hospital resuscitation
    Oliver Koeth
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Resuscitation 81:1505-8. 2010
    ..Only few data on the outcome of primary percutaneous coronary intervention (primary PCI) and thrombolysis in such patients are available...
  63. doi request reprint Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study
    Spyridon Liosis
    Department of Cardiology, Medizinische Klinik B, Herzzentrum am Klinikum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 102:671-7. 2013
    ..We therefore sought to investigate predictors of 1-year mortality in survivors of AMI treated with contemporary guideline-adherent therapy...
  64. doi request reprint Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI
    Uwe Zeymer
    Institut für Herzinfarktforschung, Ludwigshafen, Germany
    Eur J Prev Cardiol 20:218-28. 2013
    ..We sought to examine current differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI)...
  65. doi request reprint Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstraße 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 99:809-15. 2010
    ..To compare characteristics and outcome of patients with re-stenoses after prior carotid artery stenting (CAS) treated with repeat carotid interventions (Re-CI) with CAS for de novo lesions...
  66. doi request reprint Effect of an invasive strategy on in-hospital outcome and one-year mortality in women with non-ST-elevation myocardial infarction
    Kouraki Kleopatra
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Int J Cardiol 153:291-5. 2011
    ..We sought to investigate the impact of an invasive strategy in clinical practice, analyzing data from the German Acute Coronary Syndromes registry (ACOS)...
  67. doi request reprint Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry)
    Timm Bauer
    Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany
    Am J Cardiol 109:941-6. 2012
    ..39) were independent predictors of hospital death. In conclusion, MV-PCI is currently used in only 1/4 of patients with CS and MVD. An additional nonculprit PCI was not associated with a survival benefit in these high risk patients...
  68. ncbi request reprint Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    J Am Coll Cardiol 45:1769-74. 2005
    ..We sought to compare the efficacy of a filter embolic protection device (F-EPD) and a distal occlusive embolic protection device (DO-EPD) in patients undergoing carotid artery stenting (CAS)...
  69. ncbi request reprint Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice
    Timm Bauer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, Ludwigshafen, Germany
    Clin Res Cardiol 98:171-8. 2009
    ..However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events...
  70. ncbi request reprint Gender differences in acute non-ST-segment elevation myocardial infarction
    Tobias Heer
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Am J Cardiol 98:160-6. 2006
    ..They less often received acute percutaneous coronary intervention and less often were treated with clopidogrel. However, there was no difference in age-adjusted mortality in women...
  71. ncbi request reprint Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioning
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    J Heart Valve Dis 20:64-9. 2011
    ..However, a potential problem of TAVI is the development of severe aortic insufficiency after valve implantation due to a too-low implantation of the valve...
  72. doi request reprint [Temporal trends in the use of drug-eluting stents in German clinical practice]
    Bärbel Klein
    Medizinische Klinik B, Klinikum der Stadt Ludwigshafen, Herzzentrum, Ludwigshafen
    Herz 33:450-4. 2008
    ..The following study is based on data of the ALKK PCI registry and assesses the use of DES depending on patient characteristics, indication and coronary status comparing the treatment years 2003 and 2005...
  73. ncbi request reprint Evaluation of hospitals regarding outcomes and baseline risk -- an application to percutaneous coronary intervention
    Matthias Hochadel
    Institut für Herzinfarktforschung, Bremserstrasse 79, 67063 Ludwigshafen am Rhein, Germany
    Clin Res Cardiol 96:502-7. 2007
    ..We argue that this procedure might especially meet the demands of clinicians in the centres. Data from 44 hospitals in the German Cypher Stent Registry are used to exemplify the proposed procedure...
  74. doi request reprint The development of door-to-angiography time in the last 14 years for patients with acute ST-elevation myocardial infarction treated with primary coronary intervention: Determinants and outcome. Results from the MITRAplus and OPTAMI registry
    Frank Towae
    Klinikum Ludwigshafen, Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Acute Card Care 13:35-9. 2011
    ..To examine the development of door-to-angiography time (DTA) and to evaluate the impact of door-to-angiography time in patients with ST-elevation myocardial infarction (STEMI) on hospital and one-year mortality...
  75. ncbi request reprint [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry]
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen
    Herz 29:181-6. 2004
    ..Under the circumstances of frozen medical budgets in Germany, there may also be a shift toward implantation of a drug-eluting stent (DES) for indications not yet evaluated by RCTs...
  76. doi request reprint Characteristics and clinical outcome of 458 patients with acute myocardial infarction requiring mechanical ventilation. Results of the BEAT registry of the ALKK-study group
    Kleopatra Kouraki
    Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    Clin Res Cardiol 100:235-9. 2011
    ..Information about the clinical course of patients with acute myocardial infarction requiring mechanical ventilation is scarce. We sought to evaluate the clinical outcome of a large cohort of such patients in clinical practice...
  77. doi request reprint Clinical, angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathy
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 97:623-7. 2008
    ..The aim was to assess clinical, angiographic and cardiovascular magnetic resonance (CMR) findings in patients with Takotsubo cardiomyopathy...
  78. doi request reprint Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction
    Arne Kristian Schwarz
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Future Cardiol 5:43-9. 2009
    ..Thus, a large randomized trial is warranted to further evaluate the role of enoxaparin in these patients...
  79. pmc In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbe
    R Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Heart 91:1041-6. 2005
    ..To determine the predictors of time between presentation and primary angioplasty and the influence of this delay time on in-hospital mortality in clinical practice...
  80. ncbi request reprint [Acute myocardial infarction after discontinuing aspirin two years after implantation of a drug-eluting coronary stent]
    P Krüth
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen Rhein
    Dtsch Med Wochenschr 132:201-4. 2007
    ..Eight days before admission aspirin was discontinued because a tooth extraction was planned. DIAGNOSTIC PROCEDURES: The ECG showed significant ST-segment elevation in the precordial leads V1-5...
  81. ncbi request reprint Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group
    U Zeymer
    Stadtische Kliniken Kassel, Medizinische Klinik II, Germany
    Am Heart J 137:34-8. 1999
    ..Therefore there might be a difference in the effect of time to treatment on the efficacy of these fibrinolytics with different fibrin specificity in patients with acute myocardial infarction...
  82. ncbi request reprint [Predictive value of an ischemia test in men and women with stable angina pectoris in clinical practice. Results of the heart catheter registry of the Working Society of Senior Hospital Cardiologists]
    J Friedrich
    Herzzentrum Ludwigshafen, Medizinische Klinik B
    Dtsch Med Wochenschr 131:1078-84. 2006
    ..This study sought to evaluate the difference between the predictive value of a stress test in clinical practice for the diagnosis of significant coronary heart disease (CHD: stenosis > 50%) between women and men with stable angina...
  83. doi request reprint [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen
    Dtsch Med Wochenschr 135:1589-95. 2010
    ....
  84. ncbi request reprint Carotid artery stenting in clinical practice results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:163-72. 2005
    ..However, its feasibility and safety in clinical practice at a broad spectrum of hospitals needs to be determined...
  85. pmc Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice
    T Heer
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Heart 92:1484-9. 2006
    ..To assess the safety and effectiveness of abciximab in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in clinical practice...
  86. ncbi request reprint [Monitoring after acute myocardial infarction]
    K Muth
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen
    Dtsch Med Wochenschr 132:2021-3. 2007
    ..In patients with complications such as recurrent angina, congestive heart failure, complex ventricular arrhythmias longer monitoring over 48-72 and hospital stays over 7-14 days seem necessary...
  87. ncbi request reprint "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 93:287-94. 2004
    ..Therefore, actual clinical practice may be very different to RCT...
  88. ncbi request reprint Large myocardial infarction and a severe spasm of the left coronary artery
    B Mark
    Herzzentrum Ludwigshafen, Kardiologie Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67073 Ludwigshafen, Germany
    Z Kardiol 93:968-70. 2004
    ..The new technique of contrast-enhanced cardiac magnetic resonance imaging was used to confirm the diagnosis...
  89. doi request reprint [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]
    Ralf Zahn
    Chefarzt der Medizinischen Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen
    Herz 34:211-7. 2009
    ..However, at least in regions with a high density of invasive centers, such networks should take the investigators' experience and the annual interventional volumes of the participating hospitals into account...
  90. ncbi request reprint [Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]
    R Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Allemagne
    Ann Cardiol Angeiol (Paris) 53:36s-39s. 2004
  91. doi request reprint [Interventional therapy of acute myocardial infarction]
    R Zahn
    Kardiologie, Pneumologie, Angiologie und Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    Internist (Berl) 49:1038-46. 2008
    ..In Germany this goal is achievable almost everywhere. Therefore it is currently the most important task to establish local networks to reach this goal...
  92. doi request reprint [In-stent-stenosis of a bare-metal stent 11 years after its implantation]
    A C Skarlos
    Herzzentrum, Kardiologie, Klinikum Ludwigshafen
    Dtsch Med Wochenschr 135:1067-70. 2010
    ..A balloon angioplasty of his left anterior descending artery had been performed 12 years ago and two bare-metal stents had been implanted two months later for an early restenosis...
  93. ncbi request reprint Embolic protection devices for carotid artery stenting: better results than stenting without protection?
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Eur Heart J 25:1550-8. 2004
    ..However, CAS itself can cause cerebral ischaemic events. Embolic protection devices (PD) promise to reduce the incidence of these events...
  94. ncbi request reprint An unusual cause of dyspnoea and pulmonary hypertension in a patient with a symptom history of 20 years--"Just do it again"
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 95:68-71. 2006
  95. ncbi request reprint Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes
    Timo Lenderink
    Atrium Medical Centre, Heerlen, The Netherlands
    Eur Heart J 27:1799-804. 2006
    ..However, it remains uncertain how soon statins should be started after an acute coronary syndrome (ACS). Recently published trials suggest starting before discharge. We hypothesize that statins should be initiated without delay...
  96. ncbi request reprint Why do we need prospective registries in patients with acute myocardial infarction?
    Uwe Zeymer
    Eur Heart J 24:1611-2. 2003
  97. ncbi request reprint Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry
    Ralf Zahn
    Klinikum Swfd, Kardiologie, Nurnberg, Germany
    Am Heart J 152:1146-52. 2006
    ....
  98. ncbi request reprint Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)
    Benjamin A Steinberg
    Thrombolysis in Myocardial Infarction TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 99:1212-5. 2007
    ..In conclusion, use of evidence-based, guideline-recommended therapies in outpatients with CAD needs to improve, especially in medically managed patients...
  99. ncbi request reprint Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry)
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 99:1288-93. 2007
    ..This low risk along with the less invasive nature of the procedure should make CAS an attractive and perhaps preferred option for the treatment of these patients...
  100. ncbi request reprint Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry
    Ralf Zahn
    Städtisches Klinikum, Med Klinik 8, Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg, 90471 Nürnberg, Germany
    Eur Heart J 28:370-5. 2007
    ..We tried to determine the influence of age on complication rates of carotid artery stenting (CAS)...
  101. ncbi request reprint Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial
    Sorin J Brener
    Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Coll Cardiol 39:377-86. 2002
    ..This study was designed to test the hypothesis that eptifibatide and reduced-dose tissue plasminogen activator (t-PA) will enhance infarct artery patency at 60 min in patients with acute myocardial infarction (AMI)...